Literature DB >> 20934629

Infants with low immunoglobulin levels: Isolated low IgA level vs other immunoglobulin abnormalities.

Alexandra Horwitz1, Shiang-Ju Kung, Stephen J McGeady.   

Abstract

BACKGROUND: The International Union of Immunological Societies defined transient hypogammaglobulinemia of infancy as decreased IgG and IgA levels. Some others, however, include decreased IgA level alone. We compared infants with decreased levels of IgG and IgA, all isotypes, and IgA alone.
OBJECTIVE: To determine whether infants presenting with diminished IgA only differ clinically and in time of immunoglobulin recovery, from those with decreased levels of IgG and IgA, or of all major isotypes.
METHODS: Eighty-seven term infants found to have immunoglobulin isotype(s) 2 or more SDs below mean, normal antibody response, intact cellular immunity, and absence of other immunodeficiency syndrome features were evaluated between January 1, 1977 and December 31, 2008. Infants had decreased IgA level (group 1, n = 43), decreased IgA and IgG levels (group 2, n = 39), or low IgA, IgG, and IgM levels (group 3, n = 5).
RESULTS: Groups had similar histories. Immunoglobulins normalized in a similar percentage of all groups during infancy but earlier for group 1 (P = .005).
CONCLUSION: Little reason exists to separate infants with isolated decreased IgA levels from those with decreased levels of IgA and IgG or all isotypes.
Copyright © 2010 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20934629     DOI: 10.1016/j.anai.2010.07.009

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  2 in total

1.  Phenotypic parameters predict time to normalization in infants with hypogammaglobulinemia.

Authors:  Robert C Van Winkle; Walter W Hauck; Stephen J McGeady
Journal:  J Clin Immunol       Date:  2013-09-08       Impact factor: 8.317

2.  Otologic evaluation of patients with primary antibody deficiency.

Authors:  Giuseppe Magliulo; Giannicola Iannella; Guido Granata; Andrea Ciofalo; Benedetta Pasquariello; Diletta Angeletti; Fabiola La Marra; Isabella Quinti
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-02       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.